Published in Pharma Law Weekly, June 20th, 2006
The financing, led by Ventures West, included new investment groups Caisse de depet et placement du Quebec, RiverVest Venture Partners and Biogen Idec New Ventures. Also participating in the round were Texas Pacific Group (TPG) Ventures, Alta Partners, InterWest Partners, MPM Capital, Mithra Ventures, OrbiMed Advisors, and Red Abbey Venture Partners, all previous investors in MacroGenics.
Scott Koenig, president and CEO of MacroGenics, said,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.